Loading...
•
Jun 30, 2025
Pennant Group Q2 2025 Earnings Report
Pennant Group reported its second quarter 2025 operating results, showing significant revenue and net income growth compared to the prior year quarter.
Key Takeaways
The Pennant Group demonstrated robust performance in the second quarter of 2025, with total revenue increasing by 30.1% to $219.5 million and net income rising by 24.5% to $7.1 million. Both home health and hospice services and senior living segments contributed meaningfully to this growth, driven by increased admissions and improved revenue per occupied unit.
Total revenue for Q2 2025 reached $219.5 million, marking a 30.1% increase over the prior year quarter.
Net income for the second quarter was $7.1 million, up 24.5% from the previous year, with adjusted diluted EPS at $0.27.
The Home Health and Hospice Services segment saw a 32.5% revenue increase to $166.0 million, driven by higher admissions.
The Senior Living Services segment's revenue grew by 23.1% to $53.5 million, maintaining stable occupancy while increasing average monthly revenue per occupied unit.
Revenue by Segment
Forward Guidance
Management updated its 2025 annual guidance, anticipating total revenue between $852.8 million and $887.6 million, adjusted earnings per diluted share between $1.09 and $1.15, and adjusted EBITDA between $69.1 million and $72.7 million.
Positive Outlook
- The earnings guidance midpoint of $1.12 represents a significant 19.1% growth over 2024 adjusted earnings per share.
- The guidance reflects strong momentum across all segments of the business.
- Local leaders are expected to continue driving growth within existing operations.
- Significant untapped potential for organic improvement is identified.
- Exciting acquisition opportunities are on the near horizon, including the announced transaction with UnitedHealth Group and Amedisys.
Challenges Ahead
- The guidance includes additional expenses in anticipation of the transaction with UnitedHealth Group and Amedisys, but no additional earnings due to timing uncertainty.
- The guidance assumes reimbursement rate adjustments, which could be subject to change.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...